HER2 testing in gastric cancer: results of a German expert meeting
Valid HER2 testing is essential for optimal therapy of patients with HER2-positive gastric cancer and the correct use of first-line chemotherapy. While testing for HER2 status in breast cancer is routinely performed, this is not the case for HER2 testing in gastric cancer and it is usually only perf...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
11 March 2017
|
| In: |
Journal of cancer research and clinical oncology
Year: 2017, Jahrgang: 143, Heft: 5, Pages: 835-841 |
| ISSN: | 1432-1335 |
| DOI: | 10.1007/s00432-017-2374-x |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1007/s00432-017-2374-x Verlag, Volltext: https://doi.org/10.1007/s00432-017-2374-x 
|
| Verfasserangaben: | Florian Lordick, Salah-Eddin Al-Batran, Manfred Dietel, Timo Gaiser, Ralf-Dieter Hofheinz, Thomas Kirchner, Hans H. Kreipe, Sylvie Lorenzen, Markus Möhler, Alexander Quaas, Christoph Röcken, Josef Rüschoff, Andrea Tannapfel, Peter Thuss-Patience, Gustavo Baretton |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1581897294 | ||
| 003 | DE-627 | ||
| 005 | 20220815031348.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 181015s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00432-017-2374-x |2 doi | |
| 035 | |a (DE-627)1581897294 | ||
| 035 | |a (DE-576)511897294 | ||
| 035 | |a (DE-599)BSZ511897294 | ||
| 035 | |a (OCoLC)1341019605 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Lordick, Florian |d 1966- |e VerfasserIn |0 (DE-588)114389349 |0 (DE-627)52295085X |0 (DE-576)289795567 |4 aut | |
| 245 | 1 | 0 | |a HER2 testing in gastric cancer |b results of a German expert meeting |c Florian Lordick, Salah-Eddin Al-Batran, Manfred Dietel, Timo Gaiser, Ralf-Dieter Hofheinz, Thomas Kirchner, Hans H. Kreipe, Sylvie Lorenzen, Markus Möhler, Alexander Quaas, Christoph Röcken, Josef Rüschoff, Andrea Tannapfel, Peter Thuss-Patience, Gustavo Baretton |
| 264 | 1 | |c 11 March 2017 | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 15.10.2018 | ||
| 520 | |a Valid HER2 testing is essential for optimal therapy of patients with HER2-positive gastric cancer and the correct use of first-line chemotherapy. While testing for HER2 status in breast cancer is routinely performed, this is not the case for HER2 testing in gastric cancer and it is usually only performed on clinician request. An interdisciplinary German expert group (pathologists and clinicians) took the challenges of HER2 testing in gastric cancer as an opportunity to address essential aspects and questions for the practical use of HER2 testing in this indication. The recommendations made in this manuscript reflect the consensus of all participants and reflect their opinions and long-term experience in this field. | ||
| 650 | 4 | |a Consensus | |
| 650 | 4 | |a Gastric cancer | |
| 650 | 4 | |a HER2 testing | |
| 650 | 4 | |a Quality assurance | |
| 650 | 4 | |a Trastuzumab | |
| 700 | 1 | |a Gaiser, Timo |d 1975- |e VerfasserIn |0 (DE-588)1030402280 |0 (DE-627)735221685 |0 (DE-576)378226533 |4 aut | |
| 700 | 1 | |a Hofheinz, Ralf-Dieter |d 1969- |e VerfasserIn |0 (DE-588)121917517 |0 (DE-627)08161876X |0 (DE-576)292991568 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of cancer research and clinical oncology |d Berlin : Springer, 1979 |g 143(2017), 5, Seite 835-841 |h Online-Ressource |w (DE-627)253769515 |w (DE-600)1459285-X |w (DE-576)072578319 |x 1432-1335 |7 nnas |a HER2 testing in gastric cancer results of a German expert meeting |
| 773 | 1 | 8 | |g volume:143 |g year:2017 |g number:5 |g pages:835-841 |g extent:7 |a HER2 testing in gastric cancer results of a German expert meeting |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00432-017-2374-x |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s00432-017-2374-x |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20181015 | ||
| 993 | |a Article | ||
| 994 | |a 2017 | ||
| 998 | |g 121917517 |a Hofheinz, Ralf-Dieter |m 121917517:Hofheinz, Ralf-Dieter |d 60000 |d 61200 |e 60000PH121917517 |e 61200PH121917517 |k 0/60000/ |k 1/60000/61200/ |p 5 | ||
| 998 | |g 1030402280 |a Gaiser, Timo |m 1030402280:Gaiser, Timo |d 60000 |d 61100 |e 60000PG1030402280 |e 61100PG1030402280 |k 0/60000/ |k 1/60000/61100/ |p 4 | ||
| 998 | |g 114389349 |a Lordick, Florian |m 114389349:Lordick, Florian |d 50000 |e 50000PL114389349 |k 0/50000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1581897294 |e 3028738155 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"title":[{"subtitle":"results of a German expert meeting","title_sort":"HER2 testing in gastric cancer","title":"HER2 testing in gastric cancer"}],"note":["Gesehen am 15.10.2018"],"person":[{"given":"Florian","roleDisplay":"VerfasserIn","role":"aut","display":"Lordick, Florian","family":"Lordick"},{"family":"Gaiser","display":"Gaiser, Timo","roleDisplay":"VerfasserIn","role":"aut","given":"Timo"},{"family":"Hofheinz","display":"Hofheinz, Ralf-Dieter","roleDisplay":"VerfasserIn","role":"aut","given":"Ralf-Dieter"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"relHost":[{"origin":[{"publisher":"Springer","dateIssuedKey":"1979","publisherPlace":"Berlin ; Heidelberg","dateIssuedDisp":"1979-"}],"recId":"253769515","titleAlt":[{"title":"Cancer research and clinical oncology"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["1432-1335"],"zdb":["1459285-X"],"eki":["253769515"]},"language":["eng","ger"],"pubHistory":["Volume 93, issue 1 (January 1979)-"],"part":{"extent":"7","volume":"143","year":"2017","pages":"835-841","issue":"5","text":"143(2017), 5, Seite 835-841"},"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"HER2 testing in gastric cancer results of a German expert meetingJournal of cancer research and clinical oncology","note":["Gesehen am 19.03.25","Teils ungezählte Beil.: Supplement"],"title":[{"subtitle":"official organ of the Deutsche Krebsgesellschaft","title_sort":"Journal of cancer research and clinical oncology","title":"Journal of cancer research and clinical oncology"}]}],"language":["eng"],"physDesc":[{"extent":"7 S."}],"id":{"doi":["10.1007/s00432-017-2374-x"],"eki":["1581897294"]},"recId":"1581897294","name":{"displayForm":["Florian Lordick, Salah-Eddin Al-Batran, Manfred Dietel, Timo Gaiser, Ralf-Dieter Hofheinz, Thomas Kirchner, Hans H. Kreipe, Sylvie Lorenzen, Markus Möhler, Alexander Quaas, Christoph Röcken, Josef Rüschoff, Andrea Tannapfel, Peter Thuss-Patience, Gustavo Baretton"]},"origin":[{"dateIssuedKey":"2017","dateIssuedDisp":"11 March 2017"}]} | ||
| SRT | |a LORDICKFLOHER2TESTIN1120 | ||